1-4-(3-methyltriazeno)benzoic acid has been researched along with Leukemia L5178 in 1 studies
*Leukemia L5178: An experimental lymphocytic leukemia of mice. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonmassar, E; Christmas, SE; D'Atri, S; Grohmann, U; Moore, M; Romani, L; Tricarico, M | 1 |
1 other study(ies) available for 1-4-(3-methyltriazeno)benzoic acid and Leukemia L5178
Article | Year |
---|---|
Untreated or drug-treated tumor cells are differentially recognized by allogeneic lymphocytes.
Topics: Animals; Antineoplastic Agents; Clone Cells; Cytotoxicity Tests, Immunologic; Female; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Leukemia L5178; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; T-Lymphocytes, Cytotoxic; Triazenes; Tumor Cells, Cultured | 1994 |